fairoakpharm limited
fairoakpharm limited Company Information
Company Number
01553386
Website
-Registered Address
270a mitcham lane, london, SW16 6NU
Industry
Dispensing chemist in specialised stores
Telephone
02087690251
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
premila samji halai 75%
samji halai 25%
fairoakpharm limited Estimated Valuation
Pomanda estimates the enterprise value of FAIROAKPHARM LIMITED at £88.9k based on a Turnover of £336.4k and 0.26x industry multiple (adjusted for size and gross margin).
fairoakpharm limited Estimated Valuation
Pomanda estimates the enterprise value of FAIROAKPHARM LIMITED at £0 based on an EBITDA of £-42.3k and a 4.19x industry multiple (adjusted for size and gross margin).
fairoakpharm limited Estimated Valuation
Pomanda estimates the enterprise value of FAIROAKPHARM LIMITED at £165.3k based on Net Assets of £67.3k and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Fairoakpharm Limited Overview
Fairoakpharm Limited is a live company located in london, SW16 6NU with a Companies House number of 01553386. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in March 1981, it's largest shareholder is premila samji halai with a 75% stake. Fairoakpharm Limited is a mature, micro sized company, Pomanda has estimated its turnover at £336.4k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Fairoakpharm Limited Health Check
Pomanda's financial health check has awarded Fairoakpharm Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
6 Weak
Size
annual sales of £336.4k, make it smaller than the average company (£11.6m)
- Fairoakpharm Limited
£11.6m - Industry AVG
Growth
3 year (CAGR) sales growth of -16%, show it is growing at a slower rate (5.3%)
- Fairoakpharm Limited
5.3% - Industry AVG
Production
with a gross margin of 27.4%, this company has a comparable cost of product (31.8%)
- Fairoakpharm Limited
31.8% - Industry AVG
Profitability
an operating margin of -12.6% make it less profitable than the average company (3.4%)
- Fairoakpharm Limited
3.4% - Industry AVG
Employees
with 2 employees, this is below the industry average (81)
2 - Fairoakpharm Limited
81 - Industry AVG
Pay Structure
on an average salary of £22k, the company has an equivalent pay structure (£22k)
- Fairoakpharm Limited
£22k - Industry AVG
Efficiency
resulting in sales per employee of £168.2k, this is more efficient (£135.4k)
- Fairoakpharm Limited
£135.4k - Industry AVG
Debtor Days
it gets paid by customers after 73 days, this is later than average (30 days)
- Fairoakpharm Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (69 days)
- Fairoakpharm Limited
69 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Fairoakpharm Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Fairoakpharm Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 0.5%, this is a lower level of debt than the average (61.6%)
0.5% - Fairoakpharm Limited
61.6% - Industry AVG
FAIROAKPHARM LIMITED financials
Fairoakpharm Limited's latest turnover from March 2023 is estimated at £336.4 thousand and the company has net assets of £67.3 thousand. According to their latest financial statements, Fairoakpharm Limited has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0 | 0 | 0 | |||||||||||
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | -844 | -54,801 | -9,173 | |||||||||||
| Interest Payable | 0 | 0 | 157 | |||||||||||
| Interest Receivable | 1,271 | 1,009 | 1,159 | |||||||||||
| Pre-Tax Profit | -876 | -51,646 | -7,668 | |||||||||||
| Tax | -147 | 0 | 0 | |||||||||||
| Profit After Tax | -1,023 | -51,646 | -7,668 | |||||||||||
| Dividends Paid | 0 | 0 | 0 | |||||||||||
| Retained Profit | -1,023 | -51,646 | -7,668 | |||||||||||
| Employee Costs | ||||||||||||||
| Number Of Employees | 2 | 2 | 2 | 2 | 2 | |||||||||
| EBITDA* | -844 | -54,801 | -9,173 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 107,618 | 111,651 | 105,680 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 107,618 | 111,651 | 105,680 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 67,642 | 109,988 | 152,427 | 194,561 | 245,984 | 247,315 | 249,101 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,358 | 5,397 | 63,377 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 250,387 | 249,858 | 246,825 | 250,605 | 146,192 | 153,290 | 142,401 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 67,642 | 109,988 | 152,427 | 194,561 | 245,984 | 247,315 | 249,101 | 250,387 | 249,858 | 246,825 | 250,605 | 148,550 | 158,687 | 205,778 |
| total assets | 67,642 | 109,988 | 152,427 | 194,561 | 245,984 | 247,315 | 249,101 | 250,387 | 249,858 | 246,825 | 250,605 | 256,168 | 270,338 | 311,458 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 363 | 363 | 363 | 350 | 4,123 | 3,773 | 3,423 | 3,060 | 1,225 | 305 | 1,263 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,250 | 11,686 | 5,000 |
| total current liabilities | 363 | 363 | 363 | 350 | 4,123 | 3,773 | 3,423 | 3,060 | 1,225 | 305 | 1,263 | 1,250 | 11,686 | 5,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 363 | 363 | 363 | 350 | 4,123 | 3,773 | 3,423 | 3,060 | 1,225 | 305 | 1,263 | 1,250 | 11,686 | 5,000 |
| net assets | 67,279 | 109,625 | 152,064 | 194,211 | 241,861 | 243,542 | 245,678 | 247,327 | 248,633 | 246,520 | 249,342 | 254,918 | 258,652 | 306,458 |
| total shareholders funds | 67,279 | 109,625 | 152,064 | 194,211 | 241,861 | 243,542 | 245,678 | 247,327 | 248,633 | 246,520 | 249,342 | 254,918 | 258,652 | 306,458 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | -844 | -54,801 | -9,173 | |||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -147 | 0 | 0 | |||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -42,346 | -42,439 | -42,134 | -51,423 | -1,331 | -1,786 | 249,101 | 0 | 0 | 0 | -2,358 | -3,039 | -57,980 | 63,377 |
| Creditors | 0 | 0 | 13 | -3,773 | 350 | 350 | 363 | 1,835 | 920 | -958 | 1,263 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,250 | -10,436 | 6,686 | 5,000 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -8,388 | 9,865 | -67,550 | |||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -107,618 | -4,033 | 5,971 | 105,680 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 1,271 | 1,009 | 1,002 | |||||||||||
| cash flow from financing | -1,440 | 4,849 | 315,128 | |||||||||||
| cash and cash equivalents | ||||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | -250,387 | 529 | 3,033 | -3,780 | 104,413 | -7,098 | 10,889 | 142,401 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | -250,387 | 529 | 3,033 | -3,780 | 104,413 | -7,098 | 10,889 | 142,401 |
fairoakpharm limited Credit Report and Business Information
Fairoakpharm Limited Competitor Analysis
Perform a competitor analysis for fairoakpharm limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other micro companies, companies in SW16 area or any other competitors across 12 key performance metrics.
fairoakpharm limited Ownership
FAIROAKPHARM LIMITED group structure
Fairoakpharm Limited has no subsidiary companies.
Ultimate parent company
FAIROAKPHARM LIMITED
01553386
fairoakpharm limited directors
Fairoakpharm Limited currently has 2 directors. The longest serving directors include Mr Samji Halai (Apr 1994) and Mrs Premila Halai (Aug 2007).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Samji Halai | 76 years | Apr 1994 | - | Director | |
| Mrs Premila Halai | 65 years | Aug 2007 | - | Director |
P&L
March 2023turnover
336.4k
-17%
operating profit
-42.3k
0%
gross margin
27.4%
-0.49%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
67.3k
-0.39%
total assets
67.6k
-0.39%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
fairoakpharm limited company details
company number
01553386
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
March 1981
age
43
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2023
previous names
N/A
accountant
-
auditor
-
address
270a mitcham lane, london, SW16 6NU
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
fairoakpharm limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to fairoakpharm limited. Currently there are 2 open charges and 0 have been satisfied in the past.
fairoakpharm limited Companies House Filings - See Documents
| date | description | view/download |
|---|
